home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Recommendations Help Identify Patients Suitable For NSAID Treatment

 
  October, 13 2006 10:43
your information resource in human molecular genetics
 
     
Recommendations published in the October 2006 issue of Nature Clinical Practice Gastroenterology & Hepatology should help physicians to identify quickly whether or not a patient is suitable for treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). Francis Chan recommends NSAID use for patients based on their level of risk of encountering gastrointestinal or cardiovascular problems.

NSAIDs include aspirin and ibuprofen; they can reduce pain, fever and inflammation. They can be prescribed to patients with acute pain conditions such as bone cancer, or inflammation, for example arthritis. NSAID use is associated with a number of serious upper and lower gastrointestinal complications, including bleeding, perforation, and obstruction. In addition, certain NSAIDs can cause heart attacks.

Recognizing that many NSAID-related complications are predictable and preventable, Chan has reviewed the literature and produced some simple, practical recommendations to help physicians evaluate both the gastrointestinal and cardiovascular risks of individual patients in the clinic. With this information, the physician can identify who should and who should not receive NSAIDs. The recommendations also offer guidance on what kind of gastroprotective agents should be given alongside NSAIDs in patients deemed suitable for treatment.
Although research into the safety of NSAIDs continues, these recommendations provide a quick, clinically applicable means for physicians to harness the clinical benefits of NSAIDs in suitable patients, while helping them to avoid potentially fatal complications in patients for whom the risk of adverse effects is judged unacceptably high.

Author contact:

Francis KL Chan (The Chinese University of Hong Kong, Hong Kong)
Email: fklchan@cuhk.edu.hk

Editor contact:

Natalie Wilson (Senior Editor, Nature Clinical Practice Gastroenterology & Hepatology)
Email: n.wilson@nature.com

(C) Nature Clinical Practice Gastroenterology & Hepatology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.